Scarica l'app Stockscreener
3.27
0.62%
0.02
Precedente Chiudi:
$3.25
Aprire:
$3.29
Volume 24 ore:
13,455
Relative Volume:
0.46
Capitalizzazione di mercato:
$215.93M
Reddito:
$62.37M
Utile/perdita netta:
$-78.98M
Rapporto P/E:
-2.6803
EPS:
-1.22
Flusso di cassa netto:
$-57.80M
1 W Prestazione:
+3.15%
1M Prestazione:
-9.17%
6M Prestazione:
-30.87%
1 anno Prestazione:
-14.17%
Intervallo 1D:
$3.27
$3.44
Intervallo di 1 settimana:
$3.05
$3.44
Portata 52W:
$2.70
$7.37
Sophia Genetics Sa Stock (SOPH) Company Profile
Nome
Sophia Genetics Sa
Settore
Industria
Telefono
-
Indirizzo
-
Confronta SOPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.27 | 215.93M | 62.37M | -78.98M | -57.80M | -1.22 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-03 | Iniziato | BTIG Research | Buy |
| 2022-11-23 | Iniziato | Credit Suisse | Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-17 | Iniziato | Cowen | Outperform |
| 2021-08-17 | Iniziato | Credit Suisse | Outperform |
| 2021-08-17 | Iniziato | JP Morgan | Overweight |
| 2021-08-17 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sophia Genetics Sa Borsa (SOPH) Ultime notizie
SOPHiA GENETICS Reports Third Quarter 2024 Results - GuruFocus.com
Principal Financial Group Inc. Acquires 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS Launches Advanced Cancer Profiling Platform with 99.3% Accuracy | SOPH Stock News - StockTitan
SOPHiA GENETICS's SWOT analysis: data-driven medicine stock faces headwinds - Investing.com India
SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
SOPHiA GENETICS Faces Financial Challenges Amid Losses - Yahoo Finance
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com
3 Reasons Not to Give Up on Roku Stock - MSN
Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year - MSN
Cofle S.p.A. Enhances Share Buyback Strategy - MSN
Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock? - MSN
Palantir, Trump Media Buzz Amid Investors Ahead Of Election Day - MSN
SOS Limited announces ADS ratio change - MSN
Exploring Sophia Genetics's Earnings Expectations - Benzinga
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.16% - MSN
IPO Roundup: Heritage Distilling, Transten Global and more - MSN
SOPHiA GENETICS SA (SOPH): A Bull Case Theory - Insider Monkey
Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Estimating at-risk couple rates across 1000 exome sequencing data cohort for 176 genes and its importance relevance for health policies - Nature.com
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Morgan Stanley Downgrades Biogen (BIIB) - MSN
The biggest U.S. homebuilder misses on earnings as it says buyers are staying on the sidelines - MSN
Clime Capital Announces Quotation of New Shares - MSN
SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - MarketBeat
US Penny Stocks To Watch In October 2024 - Simply Wall St
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine - AsiaOne
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024 - Marketscreener.com
Millennium Management LLC Purchases 9,199 Shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) - Defense World
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 22.8% in September - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Millennium Management LLC - MarketBeat
Artificial Intelligence (AI) in Precision Medicine Global Market Size, Trends 2024-2033 - WhaTech
The UAE Cerebrospinal Fluid Drainage Catheter Market Size & Outlook, 2030 - Grand View Research
Dynamic Advisor Solutions LLC Acquires 1,432 Shares of PepsiCo, Inc. (NASDAQ:PEP) - Defense World
Artificial Intelligence in Diagnostics Market to hit USD 7.3 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
What to Expect From Labcorp Holdings' Q3 2024 Earnings Report - MSN
SOPHiA GENETICS' SWOT analysis: data-driven medicine firm faces headwinds - Investing.com
Artificial Intelligence In Cancer Diagnostics Market Size, Industry Analysis, Key Insights And Forecast To ... - WhaTech
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 52.0% in September - Defense World
Federated Hermes Inc. Has $346,000 Stake in Photronics, Inc. (NASDAQ:PLAB) - Defense World
Global Precision medicine software Market Expected to Reach $ 3112.52 Million by 2032, Growing at 11.4% CAGR - 대구포스트
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) & Cyclo Therapeutics (NASDAQ:CYTH) - Defense World
The Agenda Setter: SOPHIE’s posthumous new album cements a pop visionary’s legacy - Dork Magazine
Sosandar – AGM Due On Thursday For Women’s Fashion Group Now Recovering Into Profits, Shares Now 10p, Brokers Predict 31p - UK Investor Magazine
Sophie's life was saved by a stranger. Some in her position have an 'unfair' disadvantage - SBS News
Sophia Genetics Sa Azioni (SOPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):